HIVE

A Startup Believes AI’s Problem in Drug Discovery Is the Lack of Human Tissue Data

Vivodyne says that the AI models used in drug discovery lack causal data derived from living human tissues, and is betting on robotic laboratories to produce it. The company presents its vision as a solution to a problem beyond the capabilities of current models, not as evidence that a cancer cure is near.